Benzinga · Nov 13, 2026
Freedom Capital Markets Maintains Buy on Inspire Medical Systems, Lowers Price Target to $93
Freedom Capital Markets analyst Keith Hinton maintains Inspire Medical Systems (NYSE:INSP) with a Buy and lowers the price target from $97 to $93.

